Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial-Reference-Cited by-同舟云学术

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

Published:2010-08 Issue:9742 Volume:376 Page:687-697
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Bang Yung-Jue,Van Cutsem Eric,Feyereislova Andrea,Chung Hyun C,Shen Lin,Sawaki Akira,Lordick Florian,Ohtsu Atsushi,Omuro Yasushi,Satoh Taroh,Aprile Giuseppe,Kulikov Evgeny,Hill Julie,Lehle Michaela,Rüschoff Josef,Kang Yoon-Koo

Publisher

Elsevier BV

Subject

General Medicine

Reference32 articles.

1. Global cancer facts and figures 2007;Garcia,2007

2. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world;Kamangar;J Clin Oncol,2006

3. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

4. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution;Cunningham;J Gastrointest Surg,2005

Cited by 4977 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HER2-negative or low expression as an unfavorable prognostic factor in patients with stage I/II uterine carcinosarcoma;Journal of Gynecologic Oncology;2025

2. Immunotherapy in gastrointestinal cancers: Spotlight on the pivotal role of currently available biomarkers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

3. Immunotherapeutic strategies in gastroesophageal tumors;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

4. Tumor immune microenvironmental characteristics in Human Epidermal Growth Factor-2 (HER2) positive esophageal adenocarcinoma: A comparative analysis and biomarker study;Translational Oncology;2024-11

5. The Role of Intracellular and Extracellular Vesicles in the Development of Therapy Resistance in Cancer;Current Pharmaceutical Design;2024-10